feature photo

Publications

 

CROI2017

2017 Conference on Retroviruses and Opportunistic Infections (CROI)

 

Protocol
Title
Authors
Presentation Type
Tuesday, 14 February 2017


P1104s


Neuropsychological outcomes in a two year African-based pediatric observational study


Boivin MJ, Chernoff M, Laughton B, BwakuraDangarembizi M, Kamthunzi P, Barlow-Mosha L, Violari A, Cotton M, Palumbo P, for the IMPAACT P1104s Study Team


Poster


IMPAACT 219C


Biomarkers of cognitive decline in perinatallyinfected children with HIV


Bearden DR, Gill A, Williams PL, Kolson DL, Schankel L, Agwu A, Van Dyke RB, Douglas SD, for the IMPAACT 219C study team


Poster


IMPAACT 219C


Plasma Heme-Oxygenase-1 is associated with cognitive decline in children with HIV


Bearden DR, Gill A, Williams PL, Kolson DL, Schankel L, Agwu A, Van Dyke RB, Douglas SD, for the IMPAACT 219C study team


Poster

Wednesday, 15 February 2017


P1026s


Interaction between etonogestrel-releasing implant and 3 antiretroviral regimens


Kreitchmann R, Stek A, Best B, Capparelli E, Wang J, Shapiro DE, Chakhtoura N, Burchett S, Mirochnick M


Poster

P1072


B and T cell subsets and immunogenicity of rotavirus vaccine in PHIV and PHEU Infants


Weinberg A, Lindsey JC, Bosch R, Persaud D, Sato P, Heckman B, Richardson K, Zadzilka A, Nelson M, Levin MJ


Poster


PHOENIx IMPAACT 2003/A5300


HIV testing uptake among household contacts of MDR-TB index cases in eight countries

 

Opollo VS, Wu X, Lando R, Swindells S, Gupta A, Hesseling A, Dawson R, Hughes MD, Shah S


Poster

Thursday, 16 February 2017


P1025, DACS 711, SMARTT


TDF/FTC in pregnancy shows no increase in adverse infant birth outcomes in US cohorts


Rough K, Seage III GR, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Hoffman RM, Barr E, Shapiro DE, Patel K


Poster


P1026s


Elvitegravir/cobicistat pharmacokinetics in pregnancy and postpartum


Best B, Capparelli E, Stek A, Acosta E, Smith E, Chakhtoura N, Wang J, Hernandez A, Mirochnick M


Poster


PROMISE 1077BF/FF


Antenatal antiretroviral therapy and adverse birth outcomes: the PROMISE trial


Chi BH, Farhad M, Owor M, Chipato T, Qin M, Dadabhia S, Gnanashanmugam D, Chakhtoura N, Fowler MG, Stringer JS


Poster


PROMISE 1077BF/FF


Risk factors for low birth weight and preterm delivery in the PROMISE trial


Sebikari D, Qin M, Owor M, Stringer J, Farhad M, Chakhtoura N, Chi B, Klingman K, Theron G, Fowler MG


Poster


PROMISE 1077HS


Subsequent pregnancy outcomes in women during follow-up in PROMISE 1077HS


Pilotto JH, Brummel S, Hoffman RM, Britto P, Masheto G, Aurpibul L, Chakhtoura N, Klingman K, Currier JS


Poster


P1080


Sertraline pharmacokinetics in HIV-infected on ARV and uninfected youth


Hanan N, PAUL M, Huo Y, Capparelli E, Kapetanovic S, Ariansen JL, Smith E, Brouwers P, Best B


Poster


P1093


Dolutegravir pharmacokinetics, safety and efficacy in HIV+ children 2 to <6 years old


Ruel T, Acosta E, Singh RP, Alvero C, George K, Popson S, Vavro C, Hazra R, Wiznia A


Poster


P1106


Pharmacokinetics of nevirapine prophylaxis in HIVexposed low birth weight infants


Bekker A, Violari A, Cababasay M, Wang J, Wiesner L, Capparelli E, Cotton M, Nakwa F, Mirochnick M


Poster


P1110


Raltegravir pharmacokinetics and safety in HIV-1 exposed neonates: dose-finding study


Clarke DF, Acosta EP, Chain A, Wang J, Cababasay M, Teppler H, Smith E, Hazra R, Mirochnick M, and the IMPAACT P1110 Protocol Team


Poster


P1112


Safety & pharmacokinetics of the monoclonal antibody, VRC01, in HIV-exposed newborns


Cunningham CK, McFarland EJ, Capparelli EV, Muresan P, Perlowski C, Valentine M, Smith E, Mascola JR, Graham BS


Poster

 

← Publications Home

 

 

 

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.